Tranylcypromine, a drug for treating depression finally has got approval from the U.S. Food and Drug Administration’s (FDA). This is the sulfate tablet of 10mg. The drug is the nonspecific version of GlaxoSmithKline’s parnate. Par Pharmaceutical Companies Inc owns Kali Laboratories Inc. who made the drug.